Salient Surgical Lands $17,900,000 Series F Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5d691c02-1cf6-46bf-ba09-22782dede6a3&Preview=1 -
Date
10/29/2008 -
Company Name
Salient Surgical -
Mailing Address
One Washington Center Dover, NH 03820 -
Company Description
TissueLink Medical provides devices that reduce surgical blood loss. Utilizing TissueLink’s saline-enhanced radio-frequency technology allows surgeons to control bleeding and improve patient outcomes. -
Website
http://www.salientsurgical.com/index.htm
-
Transaction Type
Venture Equity -
Transaction Amount
$17,900,000 -
Transaction Round
Series F -
Proceeds Purposes
Salient plans to use the net proceeds to fund programs aimed at continuing to expand its sales and marketing organization and accelerating development of new advanced energy products based on its proprietary Transcollation™ technology. Salient will also use a portion of the proceeds to fund working capital requirements and amortize term debt. -
M&A Terms
-
Venture Investor
Piper Jafray Ventures -
Venture Investor
Arnerich Messina & Associates, Inc. -
Venture Investor
Medtronic -
Venture Investor
Rivervest Venture Partners
